Navigation Links
KellBenx Secures $2.5 Million Funding Round
Date:4/21/2011

NEW YORK, April 21, 2011 /PRNewswire/ -- KellBenx, a biotechnology company focused on the development of non-invasive prenatal diagnosis (NIPD) of genetic and inherited disorders, announced today that it has secured an initial funding round of $2.5 million from four investors –  three biotechnology venture capital groups and one angel investor. The round will finance a clinical trial and laboratory testing of a new, minimally invasive blood test designed to identify risks to pregnancy ranging from pre-term birth to genetic conditions.

"We are delighted to have secured this round of funding and the support of our investors," said Hassan Bennani, MD., CEO of KellBenx. "The funds will be used to launch an IRB-approved clinical trial and build our Long Island laboratory to analyze the data we are producing. We are excited about the prospects of our technology and the company going forward."

"We are extremely pleased to partner with such an esteemed group of investors," said Leonard H. Kellner, President of KellBenx. "All of our investors bring tremendous energy, intellect and resources to this partnership, and we plan on leveraging their extensive networks to accelerate the adoption of KellBenx' revolutionary technologies."

About KellBenx

Founded in 2010, KellBenx, Inc. is a privately-held biotechnology company based in New York City. KellBenx is developing high value, innovative tests that leverage the ability to extract clinically relevant information from blood.  Our focus is to improve women's healthcare and one of our first tests is in the area of non-invasive prenatal diagnosis (NIPD) for genetic disorders. For more information, please call 631.643.2614 or visit www.kellbenx.com.


'/>"/>
SOURCE KellBenx
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. KellBenx Secures Worldwide Agreement With Cedars-Sinai Medical Center for Biomarker Technology to Predict Premature Births
2. WNDM Secures Additional International Sales; $150 K in New Orders for 2011
3. BioNeutral Group Secures Three Initial Trial Orders for its Ogiene™ Odor Neutralizer & Multi-Purpose Cleaner Product Line
4. ACT Secures Patent to Generate Embryonic Stem Cells Without Embryo Destruction
5. Bacterin International Holdings Secures $5,000,000 Credit Facility with Bridge Bank
6. SeraCare Life Sciences Secures $20 Million Credit Facilities
7. Medizone International Secures $10,000,000 Funding Commitment
8. aTyr Pharma Secures $23M Financing From Top Tier Venture Investor
9. Omeros Secures $40 Million Committed Equity Financing Facility
10. SPO Medical Secures Agreement in Sleep Apnea Market
11. Biolaxy Secures IND Approval for Oral Insulin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/14/2017)... ... September 14, 2017 , ... ... CliniControl™ (CC) product portfolio, clinically-relevant starting and ancillary materials that generate unprecedented ... Stem/Stromal Cell (hMSC)-based therapies. The CliniControl product portfolio will radically simplify major ...
(Date:9/14/2017)... ... September 14, 2017 , ... AIM Global, the worldwide standards agency for ... won the 2017 Case Study Competition for AIDC. The award is given to ... risk” and push the adoption of automated data collection systems further. The TRACTUS ...
(Date:9/12/2017)... Boston, MA (PRWEB) , ... September 12, 2017 ... ... Physiology Analytics (PPA) and highly scalable cloud-based platform for ambulatory patient monitoring and ... Disruptive Innovations to Advance Clinical Trials conference in Boston. , Launched in ...
(Date:9/12/2017)... ... September 12, 2017 , ... ... 2017-2018 are asked to submit a "pre-proposal” by October 15, prior to completing ... greenlight projects that are aligned with our priorities, and to encourage researchers to ...
Breaking Biology Technology:
(Date:4/11/2017)... , Apr. 11, 2017 Research and ... Market 2017-2021" report to their offering. ... The global eye tracking market to grow at a ... report, Global Eye Tracking Market 2017-2021, has been prepared based on ... covers the market landscape and its growth prospects over the coming ...
(Date:4/5/2017)... Today HYPR Corp. , leading innovator ... of the HYPR platform is officially FIDO® Certified ... architecture that empowers biometric authentication across Fortune 500 enterprises ... over 15 million users across the financial services industry, ... product suites and physical access represent a growing portion ...
(Date:3/30/2017)... The research team of The Hong Kong Polytechnic University ... adopting ground breaking 3D fingerprint minutiae recovery and matching technology, pushing ... for use in identification, crime investigation, immigration control, security of access ... ... A research team led by Dr Ajay ...
Breaking Biology News(10 mins):